- Home
- IPI vs AVIR Comparison
IPI vs AVIR Comparison
Compare IPI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPI | AVIR |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 471.8M | 450.9M |
| IPO Year | 2007 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IPI | AVIR |
|---|---|---|
| Price | $37.03 | $5.45 |
| Analyst Decision | Strong Sell | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $25.00 | $10.00 |
| AVG Volume (30 Days) | ★ 328.9K | 293.5K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.14 | 3.00 |
| EPS | ★ 0.85 | N/A |
| Revenue | $298,328,000.00 | ★ $351,367,000.00 |
| Revenue This Year | $5.01 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $44.03 | ★ N/A |
| Revenue Growth | ★ 17.13 | N/A |
| 52 Week Low | $22.55 | $2.46 |
| 52 Week High | $50.34 | $6.45 |
Technical Indicators
Market Signals| Indicator | IPI | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 45.95 |
| Support Level | $35.98 | $3.28 |
| Resistance Level | $47.78 | $6.37 |
| Average True Range (ATR) | 2.02 | 0.22 |
| MACD | -0.34 | -0.06 |
| Stochastic Oscillator | 23.98 | 14.09 |
Price Performance
Historical ComparisonAbout IPI Intrepid Potash Inc
Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, where the firm's production facilities are located.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.